Day: August 9, 2021

CHICAGO and WARMINSTER, Penn., Aug. 09, 2021 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (GTI) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ Dispensaries, today announced it will open Rise Warminster, the 16th Rise™ location in Pennsylvania and 62nd store nationwide, on Tuesday, August 10. Profits from the first day of sales will be donated to National Giving Alliance (NGA) which works to improve the quality of life for homeless, low-income and moderate-income children, women and men by collecting and distributing new clothes, linens and toiletries. “The opening of Rise Warminster marks number 16 in the Commonwealth, our deepest dispensary footprint serving a single market and a true testament to the support of cannabis for well-being in communities across Pennsylvania,”...

ADMA Expands Commercial IG Product Offering with Additional BIVIGAM and NABI-HB Vial Sizes BIVIGAM 100 mL Vial and NABI-HB 1 mL Vial Now Commercially Available to U.S. Healthcare Providers RAMSEY, N.J. and BOCA RATON, Fla., Aug. 09, 2021 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced the commercial availability of additional vial sizes of BIVIGAM and NABI-HB, which are currently in stock and commercially available to U.S healthcare providers and patients. “The availability of these additional NABI-HB and BIVIGAM vial sizes meaningfully enhances ADMA’s go-to-market offering for its commercial Immune Globulin (“IG”) product portfolio and allows for more versatile utilization...

Cerence Third Quarter HighlightsRevenue grew 29% year-over-year Exceeded company quarterly guidance on key GAAP and non-GAAP profitability metrics Increased FY24 revenue Target from $600M to $700M, and improved key profitability metrics Record number of auto SOPs (Start Of Production) from over 15 auto OEMs Strategic collaborations announced in the quarter with Sirius XM, Visteon and HarmanBURLINGTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today reported its third fiscal quarter 2021 results for the quarter ended June 30, 2021. Results Summary (1)(in millions, except per share data)    Three Months Ended     Nine Months Ended      June 30,     June 30,      2021       2020       2021       2020    GAAP Revenue     $96.8         $75.2         $289.1         $239.7    GAAP...

Else readying for distribution at online platforms of Nation’s Leading Grocery Retail Chain VANCOUVER, British Columbia, Aug. 09, 2021 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company, announces that it will be expanding into owned online marketplaces by Q4, 2021 with its Plant-Based Complete Nutrition products for Toddlers. The expansion also will place else at Kroger-owned Vitacost.com, an E-commerce leader in the healthy/organic foods space. “Being a part of Kroger’s E-commerce platforms mark a major step forward for our online growth strategy,” said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. “Kroger’s large on-line presence as a grocery leader, will significantly increase the accessibility...

CAMBRIDGE, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has dosed the first TP53-mutated acute myeloid leukemia (AML) patient with TTI-622 (SIRPα-IgG4 Fc), an investigational checkpoint inhibitor of the innate immune system, in combination with azacitidine. TTI-622 is a fusion protein that is designed to block the inhibitory activity of CD47, a molecule that is overexpressed by a wide variety of tumors. CD47 binds to SIRPα on macrophages and delivers a “don’t eat me” signal that inhibits the ability of macrophages to engulf and destroy cancer cells. Preclinical studies have shown that TTI-622 exhibits anti-tumor activity against AML cells as a monotherapy that is...

On track to initiate RECONNECT, a confirmatory pivotal trial of Zygel™ in patients with FXS, in the third quarter of 2021 Positive feedback from FDA clarifies potential path forward in ASD Cash runway well into the first half of 2024; $85.8 million at June 30, 2021DEVON, Pa., Aug. 09, 2021 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today reported financial results for the second quarter ended June 30, 2021, and provided an overview of recent operational highlights and a pipeline update. “We continue to make progress across our portfolio, particularly in FXS in which our confirmatory pivotal Phase 3 trial, RECONNECT, is expected to start in the third quarter of 2021,” said...

Company to host conference call on Thursday, August 12th, 2021 at 8:00 a.m. ET CHESTERBROOK, Pa., Aug. 09, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that it will release its financial results for the second quarter ended June 30, 2021, prior to the market open on Thursday, August 12th, 2021. Company management will host a conference call and webcast with the investment community at 8:00 a.m. (ET) that same day featuring remarks by Carrie Bourdow, President and Chief Executive Officer, Bob Yoder, Chief Business Officer, Mark Demitrack, SVP and Chief Medical Officer and Barry Shin, SVP and Chief Financial Officer.Title: Trevena Second Quarter 2021...

Encouraging Au/Ag and Base Metal Mineralization Identified VANCOUVER, British Columbia, Aug. 09, 2021 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V: MRZ) (OTCPK: MRZLF) (the “Company” or “Mirasol”) is pleased to report the results from the recently completed 2,814m drill program at the Sascha Marcelina Project (“Sascha Marcelina”) in Santa Cruz province, Argentina. Mirasol’s President, Tim Heenan, commented: “We are encouraged with the early results from this maiden drill program on three of our priority prospects within the Sascha Marcelina project. The Pellegrini Trend returned a broad zone of Au and Ag mineralization overprinting a younger Pb and Zn rich base metal pulse, that is interpreted to represent the high-level expression in this epithermal system. This mineralized zone may correspond to the top or the margins of...

Trial to Evaluate AVB-500 as a First-Line Treatment in Combination with Gemcitabine and Nab-Paclitaxel Continues Expansion of AVB-500 in Multiple Oncology Indications and Combinations HOUSTON, Aug. 09, 2021 (GLOBE NEWSWIRE) — Aravive Inc. (Nasdaq: ARAV), a clinical-stage oncology company developing innovative therapeutics to treat life-threatening diseases, today announced the Company has dosed the first patient in the Phase 1b portion of its Phase 1b/2 trial of AVB-500 in combination with gemcitabine and nab-paclitaxel as a first-line treatment in patients with advanced or metastatic pancreatic adenocarcinoma. The Phase 1b portion of the clinical trial will evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical activity of AVB-500 in combination with gemcitabine and nab-paclitaxel. “We are pleased with...

PHOENIX, Aug. 09, 2021 (GLOBE NEWSWIRE) — QuoteMedia, Inc. (OTCQB: QMCI), a leading provider of market data and financial applications, today announced that its earnings for its quarter ended June 30, 2021 will be released the morning of August 12, 2021. That same day, the company will host a conference call at 2:00 PM Eastern time to discuss the financial results and provide a business update. Conference Call Details: Date: August 12, 2021 Time: 2:00 PM Eastern Dial-in numbers: 877-876-9173 Conference ID: QUOTEMEDIA An audio rebroadcast of the call will be available later at: www.quotemedia.com About QuoteMedia QuoteMedia is a leading software developer and cloud-based syndicator of financial market information and streaming financial data solutions to media, corporations, online brokerages, and financial services companies....